How Nufarm Limited is planning a $627 million expansion into Europe

Nufarm Limited (ASX:NUF) buys European crop protection portfolio for $691 million.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nufarm Limited (ASX: NUF) share price isn't going anywhere after the agricultural chemical company requested its shares be placed in a trading halt.

Why are its shares in a trading halt?

In an announcement, Nufarm requested a trading halt from the ASX because of its planned acquisition of a European portfolio of crop protection products and an associated capital raising. The Melbourne-based company has agreed to purchase the European product portfolio from Adama and Syngenta. Cash consideration will be US$490 million (A$627 million) plus an additional US$50 million (A$64 million) for inventory.

The portfolio contains over 50 crop protection formulations and is expected to contribute net sales of approximately $250 million and an EBITDA of between $95-$100 million in the 2019 financial year.

The deal is expected to be EPS accretive (pre-amortisation) in the range between the mid to high-single digits. Management has stated that the acquisition is aligned with the company's overall strategy and will strengthen Nufarm's European presence where the company generates its highest crop protection margins.

The acquisition will be funded through a combination of a fully underwritten entitlement offer of approximately $446 million and $272 million from existing debt facilities. The entitlement offer will allow eligible shareholders to subscribe for 2 new shares for every existing 9 shares at $7.50 a share, a 14.1% discount to the last closing price of $8.73.

Further acquisition

The company also announced that it was currently involved in exclusive discussions with another party to purchase a crop protection portfolio. Nufarm is completing its due diligence which is expected to be finalised in the coming weeks. If this acquisition were to proceed, it would be for less than US$100 million and be fully funded from the company's existing debt facilities. The additional portfolio would contribute approximately A$30 million in revenue for the first full year of operation (FY19).

Today's announcement comes off the back of last week's broker report from Morgan Stanley. The broker initiated coverage on Nufarm issuing an outperform rating with a $10.40 price target as it believes the market has overlooked Nufarm's transformation into a quality business.

Motley Fool contributor Tim Katavic has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »